Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Long-Lasting Anti-Inflammatory Activity of Human Microfragmented Adipose Tissue.

Nava S, Sordi V, Pascucci L, Tremolada C, Ciusani E, Zeira O, Cadei M, Soldati G, Pessina A, Parati E, Slevin M, Alessandri G.

Stem Cells Int. 2019 Feb 19;2019:5901479. doi: 10.1155/2019/5901479. eCollection 2019.

2.

In Vitro Anticancer Activity of Extracellular Vesicles (EVs) Secreted by Gingival Mesenchymal Stromal Cells Primed with Paclitaxel.

Coccè V, Franzè S, Brini AT, Giannì AB, Pascucci L, Ciusani E, Alessandri G, Farronato G, Cavicchini L, Sordi V, Paroni R, Dei Cas M, Cilurzo F, Pessina A.

Pharmaceutics. 2019 Feb 1;11(2). pii: E61. doi: 10.3390/pharmaceutics11020061.

3.

Gene expression analysis of embryonic pancreas development master regulators and terminal cell fate markers in resected pancreatic cancer: A correlation with clinical outcome.

Dugnani E, Sordi V, Pellegrini S, Chimienti R, Marzinotto I, Pasquale V, Liberati D, Balzano G, Doglioni C, Reni M, Gandolfi A, Falconi M, Lampasona V, Piemonti L.

Pancreatology. 2018 Dec;18(8):945-953. doi: 10.1016/j.pan.2018.09.006. Epub 2018 Sep 25.

PMID:
30293872
4.

Differentiation of Sendai Virus-Reprogrammed iPSC into β Cells, Compared with Human Pancreatic Islets and Immortalized β Cell Line.

Pellegrini S, Manenti F, Chimienti R, Nano R, Ottoboni L, Ruffini F, Martino G, Ravassard P, Piemonti L, Sordi V.

Cell Transplant. 2018 Oct;27(10):1548-1560. doi: 10.1177/0963689718798564. Epub 2018 Sep 25.

5.

Study of 2009 H1N1 Pandemic Influenza Virus as a Possible Causative Agent of Diabetes.

Capua I, Mercalli A, Romero-Tejeda A, Pizzuto MS, Kasloff S, Sordi V, Marzinotto I, Lampasona V, Vicenzi E, De Battisti C, Bonfanti R, Rigamonti A, Terregino C, Doglioni C, Cattoli G, Piemonti L.

J Clin Endocrinol Metab. 2018 Dec 1;103(12):4343-4356. doi: 10.1210/jc.2018-00862.

PMID:
30203067
6.

Islet Allotransplantation in the Bone Marrow of Patients With Type 1 Diabetes: A Pilot Randomized Trial.

Maffi P, Nano R, Monti P, Melzi R, Sordi V, Mercalli A, Pellegrini S, Ponzoni M, Peccatori J, Messina C, Nocco A, Cardillo M, Scavini M, Magistretti P, Doglioni C, Ciceri F, Bloem SJ, Roep BO, Secchi A, Piemonti L.

Transplantation. 2019 Apr;103(4):839-851. doi: 10.1097/TP.0000000000002416.

PMID:
30130323
7.

Pluripotent stem cell replacement approaches to treat type 1 diabetes.

Pellegrini S, Piemonti L, Sordi V.

Curr Opin Pharmacol. 2018 Dec;43:20-26. doi: 10.1016/j.coph.2018.07.007. Epub 2018 Jul 30. Review.

PMID:
30071348
8.

The potential and challenges of alternative sources of β cells for the cure of type 1 diabetes.

Cito M, Pellegrini S, Piemonti L, Sordi V.

Endocr Connect. 2018 Mar;7(3):R114-R125. doi: 10.1530/EC-18-0012. Review.

9.

A Nonenzymatic and Automated Closed-Cycle Process for the Isolation of Mesenchymal Stromal Cells in Drug Delivery Applications.

Coccè V, Brini A, Giannì AB, Sordi V, Berenzi A, Alessandri G, Tremolada C, Versari S, Bosetto A, Pessina A.

Stem Cells Int. 2018 Feb 20;2018:4098140. doi: 10.1155/2018/4098140. eCollection 2018.

10.

miR-204 is associated with an endocrine phenotype in human pancreatic islets but does not regulate the insulin mRNA through MAFA.

Marzinotto I, Pellegrini S, Brigatti C, Nano R, Melzi R, Mercalli A, Liberati D, Sordi V, Ferrari M, Falconi M, Doglioni C, Ravassard P, Piemonti L, Lampasona V.

Sci Rep. 2017 Oct 25;7(1):14051. doi: 10.1038/s41598-017-13622-7.

11.

Immunological Issues After Stem Cell-Based β Cell Replacement.

Sordi V, Pellegrini S, Piemonti L.

Curr Diab Rep. 2017 Sep;17(9):68. doi: 10.1007/s11892-017-0901-4. Review.

PMID:
28726153
12.

Stem cells to restore insulin production and cure diabetes.

Sordi V, Pellegrini S, Krampera M, Marchetti P, Pessina A, Ciardelli G, Fadini G, Pintus C, Pantè G, Piemonti L.

Nutr Metab Cardiovasc Dis. 2017 Jul;27(7):583-600. doi: 10.1016/j.numecd.2017.02.004. Epub 2017 Feb 21. Review.

PMID:
28545927
13.

Duodenal Mucosa of Patients With Type 1 Diabetes Shows Distinctive Inflammatory Profile and Microbiota.

Pellegrini S, Sordi V, Bolla AM, Saita D, Ferrarese R, Canducci F, Clementi M, Invernizzi F, Mariani A, Bonfanti R, Barera G, Testoni PA, Doglioni C, Bosi E, Piemonti L.

J Clin Endocrinol Metab. 2017 May 1;102(5):1468-1477. doi: 10.1210/jc.2016-3222.

PMID:
28324102
14.

MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells.

Sebastiani G, Valentini M, Grieco GE, Ventriglia G, Nigi L, Mancarella F, Pellegrini S, Martino G, Sordi V, Piemonti L, Dotta F.

Acta Diabetol. 2017 Mar;54(3):265-281. doi: 10.1007/s00592-016-0955-9. Epub 2016 Dec 30.

PMID:
28039581
15.

Establishment, characterization and long-term culture of human endocrine pancreas-derived microvascular endothelial cells.

Sordi V, Ferri A, Ceserani V, Ciusani E, Dugnani E, Pellegrini S, Nano R, Pecciarini L, Pessina A, Pascucci L, Piemonti L, Alessandri G.

Cytotherapy. 2017 Jan;19(1):141-152. doi: 10.1016/j.jcyt.2016.10.005. Epub 2016 Nov 11.

PMID:
27842980
16.

IL-7 Mediated Homeostatic Expansion of Human CD4+CD25+FOXP3+ Regulatory T Cells After Depletion With Anti-CD25 Monoclonal Antibody.

Vignali D, Gürth CM, Pellegrini S, Sordi V, Sizzano F, Piemonti L, Monti P.

Transplantation. 2016 Sep;100(9):1853-61. doi: 10.1097/TP.0000000000001276.

PMID:
27306531
17.

Paclitaxel-releasing mesenchymal stromal cells inhibit the growth of multiple myeloma cells in a dynamic 3D culture system.

Bonomi A, Steimberg N, Benetti A, Berenzi A, Alessandri G, Pascucci L, Boniotti J, Coccè V, Sordi V, Pessina A, Mazzoleni G.

Hematol Oncol. 2017 Dec;35(4):693-702. doi: 10.1002/hon.2306. Epub 2016 Jun 10.

PMID:
27283119
18.

The state of the art of islet transplantation and cell therapy in type 1 diabetes.

Pellegrini S, Cantarelli E, Sordi V, Nano R, Piemonti L.

Acta Diabetol. 2016 Oct;53(5):683-91. doi: 10.1007/s00592-016-0847-z. Epub 2016 Feb 29. Review.

PMID:
26923700
19.

The Human Pancreas as a Source of Protolerogenic Extracellular Matrix Scaffold for a New-generation Bioartificial Endocrine Pancreas.

Peloso A, Urbani L, Cravedi P, Katari R, Maghsoudlou P, Fallas ME, Sordi V, Citro A, Purroy C, Niu G, McQuilling JP, Sittadjody S, Farney AC, Iskandar SS, Zambon JP, Rogers J, Stratta RJ, Opara EC, Piemonti L, Furdui CM, Soker S, De Coppi P, Orlando G.

Ann Surg. 2016 Jul;264(1):169-79. doi: 10.1097/SLA.0000000000001364.

20.

Gemcitabine-releasing mesenchymal stromal cells inhibit in vitro proliferation of human pancreatic carcinoma cells.

Bonomi A, Sordi V, Dugnani E, Ceserani V, Dossena M, Coccè V, Cavicchini L, Ciusani E, Bondiolotti G, Piovani G, Pascucci L, Sisto F, Alessandri G, Piemonti L, Parati E, Pessina A.

Cytotherapy. 2015 Dec;17(12):1687-95. doi: 10.1016/j.jcyt.2015.09.005. Epub 2015 Oct 21.

PMID:
26481416

Supplemental Content

Support Center